Overall Technical outlook

Price Summary

On 2026-04-09, GLAND's stock started at 1728.5, reached a high of 1755.6, fell to 1721.8, and ended 1.19% higher at 1749.1, with 31350 shares traded.
During the past 52 weeks, the highest stock price was 2102.1, and the lowest was 0.0.
13 analysts forecast that the price of GLAND will range from 1525.0 to 2500.0, with an average expected price near 1964.3077.

Technicals

Support and Resistance: The current price of 1749.1 for GLAND is supported at 1666.3 and faces resistance at 1769.8. These levels indicate that 1666.3 could act as a floor, while 1769.8 might limit any further price increases.
GLAND supportResistance c2d8f1
Support/Resistance for GLAND


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
GLAND aroon c2d8f1
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
GLAND bbands c2d8f1
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR for GLAND maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
GLAND psar c2d8f1
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
GLAND stoch c2d8f1
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bullish trend, reinforced by the upward slopes of these averages. This indicates a mildly bullish overall trend, pointing to a market environment where gains are expected to be gradual and steady for GLAND. Investors may see this as a sign of a stable market with potential for modest growth over time.
GLAND trippleSMA c2d8f1
Tripple SMA chart for Gland Pharma Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.